Posts

Showing posts from August, 2023

Focusing Short Term and Expecting Long Term – Asrar Qureshi’s Blog Post #842

Image
Focusing Short Term and Expecting Long Term – Asrar Qureshi’s Blog Post #842 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #842 for Pharma Veterans. Pharma Veterans aims to share knowledge and wisdom from Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Diva Palavalaguna Photo Credit: RDNE Stock Project Photo Credit: Thirdman James Heskett is UPS Foundation Professor Emeritus at the Harvard Business School. He is a regular contributor to HBS Working Knowledge, and his articles are always deeply thought provoking. Primary thought for this post comes from his August 2023 article titled ‘As Leaders, Why Do We Continue to Reward A, While Hoping for B?’. (Link at the end). His article focuses on corporates, which I shall take up in this post with particular reference to the working in Pharma Industry. I am goin

Encouraging Bad and Expecting Good – Asrar Qureshi’s Blog Post #841

Image
Encouraging Bad and Expecting Good – Asrar Qureshi’s Blog Post #841 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #841 for Pharma Veterans. Pharma Veterans aims to share knowledge and wisdom from Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Mikhail Nilov Photo Credit: Markus Spiske Photo Credit: Asad Photo Maldives Photo Credit: Atta Putta Gunawan James Heskett is UPS Foundation Professor Emeritus at the Harvard Business School. He is a regular contributor to HBS Working Knowledge, and his articles are always deeply thought provoking. Primary thought for this post comes from his August 2023 article titled ‘As Leaders, Why Do We Continue to Reward A, While Hoping for B?’. ( Link at the end ). His article focuses on corporates, which I shall take up in the next post with particular reference to the worki

Deflation in China – Asrar Qureshi’s Blog Post #840

Image
Deflation in China – Asrar Qureshi’s Blog Post #840 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #840 for Pharma Veterans. Pharma Veterans aims to share knowledge and wisdom from Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Bryanken Photo Credit: Ivan Samkov Photo Credit: Mr. Dong In Pakistan, we are suffering from severe inflation. The prices are going up and the government is adding fuel to fire by raising prices of fuel, electricity, gas, crop buying, and by increasing wages of government employees by 35%. Every increase in this area adds to inflation. People are suffering hugely while the government does not seem to care. We are almost in a state of hyperinflation and the life is really biting everyone. While inflation represents rising prices, its opposite is ‘deflation’ which represents decreasi

Policies - Compliance - Culture – Asrar Qureshi’s Blog Post #839

Image
Policies - Compliance - Culture – Asrar Qureshi’s Blog Post #839 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #839 for Pharma Veterans. Pharma Veterans aims to share knowledge and wisdom from Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Elizabeth Holmes - CEO Theranos Pfizer gabapentin Pharmaceutical industry is regarded as a highly regulated industry and rightly so. At every step, regulations are applied. The data generated during production and quality control is religiously documented and vetted at various levels. Research data is subjected to even more rigorous vetting. When the local or international teams visit for inspection, their main emphasis is on reviewing documents. The process is simple; they ask for SOPs, review these, and then ask for compliance reports. Compliance becomes the key parameter because

New Diabetes Drug – Facts Vs Misinformation – Asrar Qureshi’s Blog Post #838

Image
New Diabetes Drug – Facts Vs Misinformation – Asrar Qureshi’s Blog Post #838 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #838 for Pharma Veterans. Pharma Veterans aims to share knowledge and wisdom from Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. A friend of mine forwarded the following text to me yesterday. It is a very catchy message for diabetic patients as it promises a revolutionary ‘treatment’ for diabetes. If you remember, I had done a blog showing that Pakistan had become number #1 country in the incidence of diabetes with over 38% population suffering from it. Pakistanis are also averse to standard treatment of diabetes and keep looking for miracles which never happen. For us, this kind of message is not just misleading, it is killing.  Let me tell me that this entire message is a pack of lies, misinform

Drug Development Update – Asrar Qureshi’s Blog Post #837

Image
 Drug Development Update – Asrar Qureshi’s Blog Post #837 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #837 for Pharma Veterans. Pharma Veterans aims to share knowledge and wisdom from Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Pavel Danilyuk Photo Credit: Pixabay Photo Credit: RF._. studio Periodically, I bring to you the update on new registrations by the USFDA. USFDA approval is most relevant because most research is happening in the US, and USFDA is mostly the first regulatory authority to approve new drugs, line extensions, new combinations, and expansion of indications. Some drugs are first applied to EMA – European Medicines Agency, but these are relatively few.  A look at new approvals is not just academic; it shows where the research is going, and where most investment is being done. It als

Why Strategies Fail to Deliver? – Asrar Qureshi’s Blog Post #836

Image
Why Strategies Fail to Deliver? – Asrar Qureshi’s Blog Post #836 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #836 for Pharma Veterans. Pharma Veterans aims to share knowledge and wisdom from Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Alena Darmel Photo Credit: emre keshavarz Photo Credit: Sora Shimazaki Pharmaceutical industry is quite fond of making strategies. Most strategies are focused on business growth; however, some strategies may be aimed at organizational development, culture transformation, and change management. Once in a while, there may be strategies for expansion and/or software installation. The success rate of most strategies is quite poor. Marketing strategies do not deliver desired growth, HR strategies do not bring about organizational change or development, and culture initiativ

In(creasing)Dependence Day 2023 – Asrar Qureshi’s Blog Post #835

Image
In(creasing)Dependence Day 2023 – Asrar Qureshi’s Blog Post #835 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #835 for Pharma Veterans. Pharma Veterans aims to share knowledge and wisdom from Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Khawar Nazir This is not a political post; it is rather a cry over what has happened and is happening to our beloved country. I was borne a few years after the partition, grew up during Ayub Khan’s regime, and suffered through successive, repressive regimes. The independence we received on 14 August 1947 was increasingly usurped by each new government; the last one acing them all. Without taking names, and names are not even required, because all of them have been the same, our country has been looted, robbed, plundered, exploited, tortured, distorted, and looted again

Organizational Culture Transformation Process – Asrar Qureshi’s Blog Post #834

Image
Organizational Culture Transformation Process – Asrar Qureshi’s Blog Post #834 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #834 for Pharma Veterans. Pharma Veterans aims to share knowledge and wisdom from Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Polina Zimmeerman Photo Credit:  Photo Credit: Yan Krukau This post has been inspired by an article written by Allan Watkinson and Rohit Kar published in Gallup® Workplace on 24 March 2023. (Link appears at the end) With all the talk and rhetoric about organizational culture, what is the process if the culture is to be built deliberately? This is the question we shall address in today’s post. Couple of basics first. The age of organization is a determining factor for the culture transformation; older organizations will take longer and harder effort to bri

Organizational Culture – Vision Mission – Asrar Qureshi’s Blog Post #833

Image
Organizational Culture – Vision Mission – Asrar Qureshi’s Blog Post #833 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #833 for Pharma Veterans. Pharma Veterans aims to share knowledge and wisdom from Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Antoni Shkraba Photo Credit: Artem Podrez Photo Credit: fauxels Corporate Values are usually displayed at all prominent places, and violation of values occurs in the shadow of these displays; like cars are parked right under No Parking sign. Like, government and private hospitals put up plaques at various places saying ‘Bakhsheesh’ is not allowed, and the attendants take it forcefully under these signs. I visited the offices of a large “Development Authority’ and just before the entrance there were five flexes saying very alarming things about bribery. The empl